These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties. Chu K, Snyder R, Econs MJ. J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529 [Abstract] [Full Text] [Related]
3. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK. Clin Lab; 2006 Jul; 52(9-10):499-509. PubMed ID: 17078477 [Abstract] [Full Text] [Related]
4. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A. Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688 [Abstract] [Full Text] [Related]
5. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Rissanen JP, Suominen MI, Peng Z, Halleen JM. Calcif Tissue Int; 2008 Feb 01; 82(2):108-15. PubMed ID: 18084692 [Abstract] [Full Text] [Related]
6. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth. Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM. J Pediatr Endocrinol Metab; 2005 Jan 01; 18(1):55-62. PubMed ID: 15679069 [Abstract] [Full Text] [Related]
7. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium. Ylipahkala H, Halleen JM, Kaija H, Vihko P, Väänänen HK. Biochem Biophys Res Commun; 2003 Aug 22; 308(2):320-4. PubMed ID: 12901871 [Abstract] [Full Text] [Related]
8. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Janckila AJ, Takahashi K, Sun SZ, Yam LT. Clin Chem; 2001 Jan 22; 47(1):74-80. PubMed ID: 11148180 [Abstract] [Full Text] [Related]
9. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese. Cheng T, Wang M, Chen Z, Eisenberg RA, Zhang Y, Zou Y, Deng Y, Wang M, Zhou L. Chin Med J (Engl); 2014 Jan 22; 127(16):2894-9. PubMed ID: 25131223 [Abstract] [Full Text] [Related]
10. Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Schönberg disease (Chloride Channel 7 Deficiency Osteopetrosis) among the sclerosing bone disorders. Whyte MP, Kempa LG, McAlister WH, Zhang F, Mumm S, Wenkert D. J Bone Miner Res; 2010 Nov 22; 25(11):2515-26. PubMed ID: 20499337 [Abstract] [Full Text] [Related]
11. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay. Wu ZQ, Zhang Y, Xie E, Song WJ, Yang RX, Yan CJ, Zhang BF, Xu HG. PLoS One; 2016 Nov 22; 11(1):e0147554. PubMed ID: 26800211 [Abstract] [Full Text] [Related]
12. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, Väänänen HK. Calcif Tissue Int; 2002 Jul 22; 71(1):20-5. PubMed ID: 12073156 [Abstract] [Full Text] [Related]
13. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum]. Uchida K, Nakanishi M, Yoh K. Rinsho Byori; 2001 Jan 22; 49(1):51-5. PubMed ID: 11215484 [Abstract] [Full Text] [Related]
14. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Hannon RA, Clowes JA, Eagleton AC, Al Hadari A, Eastell R, Blumsohn A. Bone; 2004 Jan 22; 34(1):187-94. PubMed ID: 14751577 [Abstract] [Full Text] [Related]
15. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Halleen JM. Anticancer Res; 2003 Jan 22; 23(2A):1027-9. PubMed ID: 12820342 [Abstract] [Full Text] [Related]
16. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients. Mose S, Menzel C, Kurth AA, Obert K, Breidert I, Borowsky K, Böttcher HD. Anticancer Res; 2003 Jan 22; 23(3C):2783-8. PubMed ID: 12926113 [Abstract] [Full Text] [Related]
17. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients. Chao TY, Ho CL, Lee SH, Chen MM, Janckila A, Yam LT. J Biomed Sci; 2004 Jan 22; 11(4):511-6. PubMed ID: 15153786 [Abstract] [Full Text] [Related]
18. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. Tähtelä R, Seppänen J, Laitinen K, Katajamäki A, Risteli J, Välimäki MJ. Osteoporos Int; 2005 Sep 22; 16(9):1109-16. PubMed ID: 15605190 [Abstract] [Full Text] [Related]
19. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum. Alatalo SL, Peng Z, Janckila AJ, Kaija H, Vihko P, Vaananen HK, Halleen JM. J Bone Miner Res; 2003 Jan 22; 18(1):134-9. PubMed ID: 12510815 [Abstract] [Full Text] [Related]
20. Specificity and clinical performance of two commercial TRACP 5b immunoassays. Ylipahkala H, Fagerlund KM, Janckila AJ, Houston B, Laurie D, Halleen JM. Clin Lab; 2009 Jan 22; 55(5-6):223-8. PubMed ID: 19728556 [Abstract] [Full Text] [Related] Page: [Next] [New Search]